Creator Buse, John B School of Medicine Christensen, Helene Nordahl Other Affiliation: Novo Nordisk A/S, Sborg, Denmark Harty, Brian J Other Affiliation: Carelon Research, Newton, Massachusetts, USA Cziraky, Mark J Other Affiliation: Carelon Research, Wilmington, Delaware, USA Willey, Vincent J Other Affiliation: Carelon Research, Wilmington, Delaware, USA Skibsted, Simon Other Affiliation: Novo Nordisk A/S, Sborg, Denmark Abstract INTRODUCTION: This study evaluated the long-term effectiveness of once-weekly subcutaneous semaglutide versus alternative treatment in adults with type 2 diabetes (T2D) in routine clinical practice
When should I take a GLP-1 or GLP-1/GIP
After completing these steps, safely dispose of the used needle in a sharps container
Accountability Creates Momentum Many people begin a weight loss journey feeling motivated